Risk factor
Considerable default risk
Profitability factor
Favourable analyst view
About
AddLife AB (publ), together with its subsidiaries, provides equipment, medical devices, and reagents primarily to healthcare system, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates in two segments, Labtech and Medtech. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and...
Company Valuation
Based on key historical and expected multiples, the stock is fairly valued relative to its peers. In particular, the stock is reasonably priced on P/E, of fair value on E
Target Price
The average target price of ALIF-B.ST is 194 and suggests 37% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to in
Buy
Sell